Uroflowmetry

Definition: uroflowmetry (urine flowmetry) is a non-invasive urodynamic test that measures the rate of urine flow over time during a spontaneous void, recorded by a uroflowmeter as a flow-versus-time curve.

Principle: urine flows when detrusor pressure exceeds urethral resistance. Flow therefore reflects the interaction of detrusor contractility and outlet resistance — it cannot separate the two by itself.

Parameters measured: maximum (peak) flow rate — Qmax, average flow rate, voided volume, time to peak flow, total voiding time, and the shape of the curve.

Key interpretation in older men: a Qmax below 10 mL/s on an adequate voided volume of more than 150 mL suggests either bladder outlet obstruction or impaired detrusor contractility. A voided volume under 150 mL makes the test uninterpretable.

Curve patterns: a normal trace is a smooth bell-shaped curve; a flat, low, prolonged plateau suggests obstruction (classically urethral stricture); an intermittent, fluctuating trace suggests abdominal straining or detrusor–sphincter dyssynergia; a low curve with high residual suggests detrusor underactivity.

Clinical uses: screening older men with LUTS; assessing severity and monitoring response to medical therapy for BPH; pre-operative assessment before prostatic surgery; evaluating suspected urethral stricture; and assessing voiding function during bladder retraining.

Always interpret with the post-void residual. Low flow with a high PVR indicates significant obstruction or a poorly contractile bladder; low flow with a low PVR is usually less significant. The pair together is the standard non-invasive assessment.

Limitations: it is a screening test, not a diagnostic one — it cannot distinguish obstruction from detrusor underactivity, which requires a pressure-flow (multichannel urodynamic) study. Results vary between voids, are affected by anxiety and by voided volume, and uroflowmeters, though inexpensive, are uncommon outside urology practices.

Practical points: the patient should attend with a comfortably full bladder; at least two recordings improve reliability; the test should be performed in privacy in the patient's usual voiding position; artefacts from straining or from the stream striking the funnel edge should be recognised.

Place in geriatric practice: it is a useful, non-invasive, low-risk bedside adjunct in frail older men in whom invasive urodynamics is undesirable, and it forms part of the recommended evaluation when post-void residual is elevated.

Non-invasive uroflow is explicitly endorsed in the AUA/SUFU OAB Guideline 2024 as the next step when PVR is elevated, before proceeding to invasive urodynamics or cystoscopy.

Routine pre-operative multichannel urodynamics is no longer required before prostate surgery — the UPSTREAM randomised trial across 26 hospitals showed a non-invasive pathway (symptom score, flow rate, PVR) was non-inferior for symptom outcomes, strengthening the role of uroflowmetry.

Home and smartphone-based uroflowmetry (sound-based and portable devices) has emerged since 2023, improving reliability by averaging multiple domiciliary voids and reducing clinic-related artefact — particularly attractive for frail and rural Indian patients.

Uroflowmetry is non-invasive and measures flow rate against time.

Qmax <10 mL/s on a void >150 mL is abnormal in older men.

Voided volume <150 mL makes the test uninterpretable.

Flat plateau = obstruction; intermittent trace = straining or dyssynergia.

Always pair the flow rate with a post-void residual.

It cannot distinguish obstruction from detrusor underactivity — that needs a pressure-flow study.